Weight Loss

Intro To Semaglutide

In the pursuit of wellness and control over weight-related health issues, Semaglutide stands out as a new beacon of hope. This medication is the outcome of relentless scientific exploration, reflecting a novel approach to obesity management and metabolic health.

What is Semaglutide?

Developed with precision through extensive clinical trials, Semaglutide is a significant leap in medicinal innovation for weight management treatment. As part of the GLP-1 receptor agonists family, substances that mimic the action of the glucagon-like peptide-1 hormone in the body, this hormone plays a vital role in regulating blood sugar levels and appetite , and proves to be a vital ally in interventions aimed at controlling diabetes and facilitating weight loss.

How Semaglutide Works

Semaglutide’s mechanism is straightforward yet powerful; it taps into the body’s innate hunger regulation system, reducing appetite and caloric intake. Additionally, by decelerating gastric emptying, it extends satiety and curtails the desire to eat, thus tackling the core obstacles faced during weight loss: managing hunger and reducing calorie consumption.

Semaglutide’s Impact on Health and Longevity

Beyond weight reduction,  Semaglutide plays a strategic role in mitigating risks associated with obesity—like type 2 diabetes, heart conditions, and various forms of  cancer.   By aiding in effective weight management, Semaglutide not only helps reduce the risk of these conditions but also enhances overall quality of life. Its role in the health and longevity industry is not just as a treatment but as a preventive measure, paving the way for a healthier, more vibrant life.

Side-Effects and Risk Management – Is it Safe?

While its transformative potential is remarkable, Semaglutide necessitates proper medical supervision, patience, and a comprehensive health approach. Embracing Semaglutide comes with a responsibility to understand its side effects, which may include nausea, digestive disturbances, and rarely, more  serious risks.  Adherence to medical guidance, gradual dose escalation, attentive self-monitoring, and suitable diet and exercise strategies are key to mitigating these risks and ensuring safe and healthy usage.  Semaglutide should not be used for more than 4-6 months, as per individual health requirements. Strict adherence to the advised treatment duration is essential but continuing your success protocol is key in transformative and permanent improvement to you health.

Semaglutide Administration: A Simple Weekly Routine

Semaglutide is designed for convenience with a simple subcutaneous injection once weekly. Its user-friendly administration can seamlessly integrate into various lifestyles, providing flexibility and consistency in treatment—a small yet significant weekly action for long-term health benefits.

Semaglutide

Giovane Medical buys our Semaglutide for our patients from one of the top manufactures in the country BPI Labs

BPI Labs, LLC – a wholly owned subsidiary of Belcher Pharmaceuticals, LLC – is a leading manufacturer of generic injectable medications. Their products are of the highest quality in the industry. And they strive to provide injectable products to help alleviate supply disruption and drug shortages.

Quality is the foundation of BPI Labs. Their strong quality culture is comprised of dedicated, highly skilled & experienced professionals working in strict adherence to the cGMP regulations. Through the use of robotic technologies, their pharmaceutical manufacturing produces the highest quality sterile injectables at competitive prices.


The search for effective and safe weight loss treatment seems never-ending. But the newest anti-obesity medication, Semaglutide, is still making waves more than a year after its 2021 approval by the U.S. Food and Drug Administration.

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight. Research continues to show the effectiveness of Semaglutide injections for weight loss.

What is Semaglutide?

Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating.

One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). For that reason, health care providers have used Semaglutide for more than 15 years to treat Type 2 diabetes. But GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full.

When used in conjunction with diet and exercise, it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease — in people who are obese or overweight.

How effective is Semaglutide for weight loss in non-diabetics?

There have been several anti-obesity medications that help suppress appetite and achieve weight loss. But Semaglutide performs on a new level.

An early study of 2,000 obese adults compared people using Semaglutide plus a diet and exercise program with people who made the same lifestyle changes without Semaglutide. After 68 weeks, half of the participants using Semaglutide lost 15% of their body weight, and nearly a third lost 20%. Participants who incorporated only lifestyle changes lost about 2.4% of their weight.

The bottom line

Semaglutideis an FDA-approved injectable medication for chronic weight management. It’s injected under the skin on your stomach, upper arm, or thigh once a week.

You’ll usually start with a low dose that’s slowly increased until you reach the target dose.

Semaglutide can cause side effects such as nausea, vomiting, and diarrhea, especially within the first several months of treatment.

What are the side effects of Semaglutide injections?

The side effects of Semaglutide are typically mild — especially when compared to the complications associated with overweight and obesity.

People taking Semaglutide for weight loss may experience:

● Dizziness

● Fatigue

● Gastrointestinal issues, such as diarrhea, constipation and gassiness

● Headache

● Stomach issues, including nausea, vomiting, pain or distension (bloat) Gastrointestinal issues are the most common complaint among people just starting Semaglutide. But you may be able to reduce the side effects by beginning on a lower dose and then slowly increasing the amount you take.

Avoid Semaglutide if you have:

● History of medullary thyroid cancer

● History of gallbladder disease

● History of pancreatitis

● Multiple endocrine neoplasia syndrome type 2 (MEN2)

As Seen In Vanity Fair December 2022

“It should have been no mystery, when the people of Hollywood started dropping dozens of pounds in a matter of weeks, it wasn’t that everyone had suddenly started practicing moderation and logging 10,000 steps. It seemed like overnight everyone knew someone who was injecting Semaglutide, whose brand name is Ozempic. The insulin regulator, developed by the Danish pharmaceutical giant Novo Nordisk in 2012, won FDA approval to treat type 2 diabetes five years later. It works by stimulating insulin release, which helps lower blood sugar levels and slow down food leaving the stomach, in turn making Ozempic users feel satiated for longer periods of time. When doctors noticed that patients using Ozempic were losing weight as a side effect of the drug, Novo Nordisk saw opportunity, conducting clinical trials on obese and overweight individuals to find that its drug did, in fact, lead to weight loss of about 15 percent of body mass in a few weeks or months. Soon the manufacturer started marketing a higher-dose Semaglutide, called Wegovy, to treat obesity. Injections, which, mostly, people give themselves once per week, usually take six to eight weeks to cause significant weight loss.”